Gushengtang Holdings Ltd
HKEX:2273
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
33.25
51.35
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Gushengtang Holdings Ltd
Total Equity
Gushengtang Holdings Ltd
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
G
|
Gushengtang Holdings Ltd
HKEX:2273
|
Total Equity
ÂĄ2.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
|
Total Equity
ÂĄ7.8B
|
CAGR 3-Years
12%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
||
Topchoice Medical Co Inc
SSE:600763
|
Total Equity
ÂĄ3.9B
|
CAGR 3-Years
12%
|
CAGR 5-Years
18%
|
CAGR 10-Years
20%
|
||
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
|
Total Equity
ÂĄ17.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
28%
|
||
Dian Diagnostics Group Co Ltd
SZSE:300244
|
Total Equity
ÂĄ7.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
13%
|
CAGR 10-Years
28%
|
||
Meinian Onehealth Healthcare Holdings Co Ltd
SZSE:002044
|
Total Equity
ÂĄ7.4B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
36%
|
Gushengtang Holdings Ltd
Glance View
Gushengtang Holdings Ltd. operates the neo-TCM primary care platform, which combines inviting in-person care and seamless digital health powered by internet and AI technologies. The company is headquartered in Guangzhou, Guangdong. The company went IPO on 2021-12-10. The firm operates in two segments. Medical and Health Solutions segment is engaged in providing customers with traditional Chinese medical and health services through offline medical institutions and online medical and health platforms, including consultation, diagnosis, prescription services, decoctions and physical therapy. Sales of Medical and Health Products segment is mainly responsible for the sales of related products. The firm's main products include Ejiao, Cordyceps, cubilose, dendrobium, American Ginseng and other medicinal materials. The firm also provides honey, Ejiao cake and other nutritional products.
See Also
What is Gushengtang Holdings Ltd's Total Equity?
Total Equity
2.3B
CNY
Based on the financial report for Dec 31, 2023, Gushengtang Holdings Ltd's Total Equity amounts to 2.3B CNY.
What is Gushengtang Holdings Ltd's Total Equity growth rate?
Total Equity CAGR 1Y
34%
Over the last year, the Total Equity growth was 34%.